Inicio › Cáncer de próstata › Minnesota
Ensayos clínicos de Cáncer de próstata en Minnesota
48 estudios sobre Cáncer de próstata buscan participantes en Minnesota.
Ciudades en Minnesota
- Minneapolis23 estudios
- Rochester22 estudios
- Saint Paul13 estudios
- Duluth7 estudios
- Saint Cloud6 estudios
- Brooklyn Park6 estudios
- Bloomington6 estudios
- Plymouth6 estudios
Texto oficial del estudio (inglés)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- y 48 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Essentia Health Cancer Center, Duluth
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06632977A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- Fairview Southdale Hospital, Edina
- y 8 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- University Of Minnesota, Minneapolis
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 28 sept 2026 · NCT06095089Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- M Health Fairview Clinics and Surgery Center, Minneapolis
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Avera Cancer Institute - Marshall ( Site 0122), Marshall
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
- HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 sept 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Rochester
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT06952803Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Mayo Clinic in Rochester, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT07650240A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT06990880Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT06925737Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Rochester
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 14 sept 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Rochester, Rochester
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology Hematology PA-Chaska, Chaska
- y 16 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05946213The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Minneapolis
ReclutandoFase 1/2
Edades de 18 a 99 · Hombres · Actualizado el 27 ago 2026 · NCT07590934A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Masonic Cancer Center, Minneapolis
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT06844383Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Minnesota Oncology - Burnsville, Burnsville
- Minnesota Oncology Hematology PA-Chaska, Chaska
- Mercy Hospital, Coon Rapids
- y 21 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 ago 2026 · NCT04423211Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Minnesota Urology, Woodbury
ReclutandoEstudio observacional
Todas las edades · Hombres · Actualizado el 18 ago 2026 · NCT07455058FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
ReclutandoFase 1
Edades de 18 a 100 · Hombres · Actualizado el 13 ago 2026 · NCT05519449Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Mayo Clinic Health System-Mankato, Mankato
- Mayo Clinic in Rochester, Rochester
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 30 jul 2026 · NCT06325046MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
- Mayo Clinic in Rochester, Rochester
Reclutando
Edades de 45 a 80 · Hombres · Actualizado el 22 jul 2026 · NCT05438563Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Rochester, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 20 jul 2026 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- y 18 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Minnesota Oncology Hematology, Minneapolis
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT05413421Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- University of Minnesota, Minneapolis
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 2 jul 2026 · NCT07140900Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- y 2 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Mayo Clinic in Rochester, Rochester
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 85 · Todos los sexos · Actualizado el 10 jun 2026 · NCT06788886Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Rochester, Rochester
ReclutandoFase 4
Edades de 18 a 100 · Hombres · Actualizado el 4 jun 2026 · NCT05803941A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 12 may 2026 · NCT06879041Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 may 2026 · NCT07354919Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
- Mayo Clinic in Rochester, Rochester
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 abr 2026 · NCT06315595A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519Screening and Staging of Benign vs Malignant Pelvic Abnormalities
- Mayo Clinic in Rochester, Rochester
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT07407959De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.